Moody’s upgrades Avient’s senior secured term loan to Baa3

Moody’s affirmed Avient Corporation’s Ba2 Corporate Family Rating and upgraded its senior secured first lien term loan to Baa3 from Ba1, with a stable outlook, citing the company's substantial debt reduction efforts and improved capital structure. The rating reflects Avient's diversified market exposure, with over half of sales in less cyclical sectors, robust adjusted EBITDA margins of approximately 18.6%, and projected 4-6% EBITDA growth for 2025, despite its 3.6x gross debt leverage and exposure to cyclical industries.

Analysis

Moody's has affirmed Avient Corporation's Ba2 Corporate Family Rating and upgraded its senior secured first lien term loan to Baa3 from Ba1, signaling a tangible improvement in the company's credit profile. This upgrade is underpinned by proactive deleveraging, evidenced by a $50 million debt repayment in the second quarter and plans for an additional $100-$200 million reduction this year, which brought the term loan principal to $670 million. The credit enhancement is further supported by a structural change, replacing an ABL revolver with a cash flow revolver that ranks pari passu with the term loan. Avient's creditworthiness is anchored by its diversified end-market exposure, with 51% of 2024 sales derived from less cyclical sectors like packaging and healthcare, and 7% from the growing defense market. This mix helps mitigate risks associated with its 35% exposure to more cyclical industrial, construction, and transportation markets. Financially, the company demonstrates strong profitability with an adjusted EBITDA margin of approximately 18.6% for the twelve months ending June 2025. Management's guidance projects 4-6% EBITDA growth for 2025, driven by demand in healthcare and defense, which is expected to offset consumer weakness. However, a key constraint remains the company's elevated gross debt leverage of approximately 3.6x.

Key Decisions for Investors

• Credit investors should note the significant upgrade of the senior secured term loan to investment grade (Baa3), which enhances the loan's quality and may lead to spread compression and increased demand from a broader set of institutions.
• For equity investors, the successful deleveraging and stable outlook from Moody's reduce financial risk and improve free cash flow prospects, justifying a closer look at the company's valuation relative to its improved credit fundamentals.
• Investors should closely monitor the performance of Avient's cyclical segments, which constitute 35% of sales, and track progress on debt reduction, as the elevated 3.6x gross leverage remains the primary risk to the investment thesis.
• Consider the balance between forecasted strength in the healthcare and defense segments against persistent consumer weakness, as the company's ability to achieve its 4-6% EBITDA growth guidance for 2025 depends on this dynamic playing out as expected.